Health > Pharmacy > Drugs and Medications > I

Home >> Health >> Pharmacy >> Drugs and Medications >> I >> Ipratropium

Ipratropium is an anticholinergic drug (trade name: Atrovent®) administered by inhalation for the coarse of action of obstructive lung diseases. It acts by blocking muscarinic receptors in the lung, inhibiting bronchoconstriction and mucus secretion.

Clinical uses
Ipratropium has respiratory results similar to atropine but since it is badly absorbed into a blood, it has couple side effects (such as tachycardia) at therapeutic drugs.

These are available under a trade list Alti-Ipratropium (AltiMed), Apo-Ipravent (Apotex), Atrovent Inhalation Aerosol (Boehringer Ingelheim), Atrovent Inhalation Guide (Boehringer Ingelheim), Atrovent Nasal Spray (Boehringer Ingelheim), Gen-Ipratropium (Genpharm), Novo-Ipramide (Novopharm), Nu-Ipratropium (Nu-Pharm), PMS-Ipratropuim (Pharmascience).

Sources
Brenner, G. M. (2000). Pharmacological medicine. Philadelphia, PA: W.B. Saunders Company. ISBN 0-7216-7757-6 Canadian Druggist Association (2000). Compendium of Pharmaceutic & Specialties (Twenty-fifth ed.). Toronto, In: Webcom. ISBN 0-919115-76-4

Ipratropium
Information from the RxList.

DrugDigest: Ipratropium Inhalation ( Atrovent nasal )
Information on dosage, usage, side effects, interactions, and drug comparisons, including generics when available.

Combivent
Information on living better with COPD (chronic obstructive pulmonary disease). Details about Atrovent MDI and the Combivent IA Inhaler.